With its grocery store operations in the Southeast, Ingles Markets has produced impressive growth. But will Kroger's buyout of Harris Teeter threaten Ingles in its home territory? Find out here.
Wal-Mart slumps on minimum wage concerns; GDP numbers released.
Fed interest rate fears send major U.S. indexes lower.
Kroger has worked hard to try to bridge the gap between traditional grocers Safeway and SUPERVALU and higher-end offerings from Whole Foods. Will its expansion strategy pan out?
The CVS Caremark acquisition of Coram is a good deal for investors.
The oft-overlooked home infusion and alternative site infusion market represents a huge opportunity for CVS Caremark with its recent acquisition of leading infusion provider Coram Specialty Infusion Services.
Will Rite Aid’s stock continue to rise? How is the company doing compared to its peers including Walgreen and CVS Caremark?
United Natural Foods has done a great job of cashing in on the same organic and natural food trends that have lifted Whole Foods, but can it beat Sysco in the lucrative niche?
A $2.1 billion investment from CVS catapults it into the leading provider of infusion drug services for patients; better positioning it against competitors Walgreen (WAG) and Rite-Aid (RAD).
Rite Aid's stock has broken out during this holiday week, leaving many investors to wonder how much higher can it trade and if it is still the best investment in the pharmacy space.